BRCA1 and cancer: For example, PARP1 promotes the repair of ssDNA breaks, which, unless repaired, can become DSBs, and PARP inhibitors therefore selectively target cancer cells with defective DSB repair ability and have thus been used to treat breast cancer patients carrying BRCA1 or 2 mutations75.